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PROMOTER SEQUENCES FROM HEVEA BRASILIENSIS HEVEIN GENES 
Technical Field 
The present invention relates to the isolation of DNA sequences 
5 from the Hevea brasiliensis containing the promoter and regulatory 
region of hevein genes, and to demonstrate their functionality in 
Hevea as well as in heterologous systems. The present invention 
also provides a recombinant expression cassette comprising the 
hevein promoter and a heterologous polynucleotide placed under 
10 transcriptional control of said promoter. The present invention 
further provides recombinant expression vectors comprising an 
expression cassette of the invention, introduced into host cells 
and plants to produce transformed cells and transgenic plants. For 
that purpose, chimaeric gene constructs containing hevein 5' 
15 flanking DNA linked to the uidA reporter gene was prepared and 
introduced into Hevea callus, and for some of the constructs, in 
model plants (rice or Arabidopsis) . Functional analysis conducted 
by ~istochemical analysis and by measuring the ~-glucuronidase 
enzyme activity, in various contexts revealed the functionality of 
20 the hevein promoter in transformed cells and transgenic plants. 
The promoter sequences of the hevein genes also acts as an 
inducible promoter regulated by wounds and pathogen infection. 
Background of the invention 
25 Hevea brasiliensis (Willd. Ex Adr. Juss) is a tropical perennial 
euphorbiaceae originating from the Amazon. It is from far the main 
crop exploited for the production of natural rubber in the world. 
In Hevea brasiliensis, natural rubber occurs as a suspension of 
cis-1, 4polyisoprene particles (from O. 01 to 15 µm in size) 
30 surrounded by a single membrane, in the latex, which is the 
cytoplasm of specialized cells called laticifers. Genetie 
engineering of Hevea brasiliensis may be one way to improve the 
yield of natural rubber production, by over-expressing favorable 
genes of the latex metabolism or by improving the defenses of the 
35 tree. It is also an interesting tool for the production of 
recombinant proteins of industrial interest (YEANG et al., 
2 
Engineering Crop Plants for Industrial End Uses, (Shewry,P., 
Napier,J., Davis,P. eds), pp.5563, Portland Press Proceedings, 
1998; AROKIARAJ, Molecular Biology of Woody Plants, volume 2 
(Mohan,S.J. and Minocha,S.C. eds), pp.305-325, Kluwer Academic 
5 Publishers, The Netherlands, 2000). An Agrobacterium tumefaciens-
mediated transformation procedure of the Hevea brasiliensis 
cultivar Gl 1 has been established (AROKIARAJ et al., Plant Cell 
Rep. 17, 621-625, 1998) and other procedures are being set up, on 
other, high yielding, cultivars (MONTORO et al., Plant Cell 
10 Reports 19, 851-855, 2000; RATTANA et al., Thai Journal of 
Agricultural Science 34(3), 2001). Genetie engineering programs 
requ_ire the use of efficient promoters, well adapted to the plant 
and the application aimed, in order to optimize the expression of 
the transgene at the right place and the right moment. 
15 The latex vessels, formed by reticulated chains of contiguous 
anastomosed cells, are periodically emitted from the cambium 
towards the phloem, as concentric rings. Upon tapping (excision of 
a thin layer of the trunk bark about 1 mm thick), the latex 
vessels are severed and the latex flows out, until latex 
20 coagulation processes occur to plug the wound. Upon centrifugation 
at high speed, the expelled latex separates into three fractions: 
the rubber fraction, the C (cytosol) -serum and the "bottom" 
fraction composed of sedimentable organelles, mainly vacuolar 
elements known as lutoids. The B-serum, fluid found insides the 
25 lutoids, is very rich in proteins. One of the major proteins in 
the B-serum is hevein (ARCHER et al., Rubber Res. Inst. Malaya 21, 
560-569, 1969), that represents 50-70% of the B-serum soluble 
proteins and about 2 to 2.8 mg per ml of total latex. Hevein is a 
small single chain prote in of 43 amino acids, unusually rich in 
30 cysteine and glycine (WALUJONO et al., Proc. Internat. Rubber 
Conf., Kuala Lumpur, pp 518-531, 1975). It is a monomer and has an 
apparent molecular weight of 9.5 kDa as determined by gel 
filtration and SDS-PAGE (VAN PARIJS et al., Planta 183, 258-264, 
1991). It is a chitin-binding protein that participates in the 
35 latex coagulation processes when released in the cytosol, by 
fixing the N-acetyl-D-glucosamine moiety of a receptor protein 
.. 
3 
located at the surface of the rubber particles, therefore 
promoting their agglutination and the plugging of the tapping eut 
(GIDROL et al., J. Biol. Chem. 269, 9278-9283, 1994). 
The mature hevein originates from a 204 aminoacids precursor 
5 protein which is matured by co- and post-translational processing, 
gi ving rise to 2 distinct domains (BROEKAERT et al. r Proc. Nat 1. 
Acad. Sei. U.S.A. 87, 7633-7637, 1990; LEE et al., J. Biol. Chem. 
266 (24), 15944-15948, 1991): the 43 aminoacids N-terminal chitin-
binding domain (hevein), specific of the lectins superfamily (VAN 
10 DAMME et al.r Plant Physiol. 119, 1547-1556, 1999) and a 144 
aminoacids C-terminal domain, homologous to the wound-inducible 
proteins WINl and WIN2 from pota to ( STANFORD et al. , Mol. Gen. 
Genet. 215, 200-208, 1989) and to type IV Pathogenesis-related 
proteins (PR-IV) isolated from tobacco and tomato (FRIEDRICH et 
15 al., Mol. Gen. Genet. 230, 113-119, 1991; LINTHORST et al., Mol. 
Plant Microbe Interact. 4, 586-592, 1991; VAN DAMME et al., 1999, 
cited above). In Hevear prohevein can thus be classified as a PR-
IV protein of class I, characterized by the presence of the 
chitin-binding N-terminal domain (VAN DAMME et al. r 1999, cited 
20 above). In addition to these sequence homologies with PR proteins, 
other evidences suggest that hevein plays a role in defense. The 
hevein capacity to inhibit fungal growth was demonstrated in vitro 
(VAN PARIJS et al., 1991, cited above). In transgenic tomato 
plants, hevein, although poorly cleaved, displayed effective 
25 antifungal properties (LEE and RAIKHEL, Brazilian Journal of 
Medical & Biological Research 28, 743-750, 1995). 
Additionally, in Hevea, hevein is expressed at a high level in the 
latex compared to leaves, and is over-expressed by wounding, 
ethylene, and ABA (BROEKAERT et al., Proc. Natl. Acad. Sei. U.S.A. 
30 87, 7633-7637, 1990). 
In conclusion, hevein is proposed to participate in the protection 
of the Hevea trunk tissues, recurrently severed by the tapping 
process, by allowing the sealing of the tapping eut through the 
latex coagulation process and by preventing pathogenic infection. 
.. 
5 
4 
Only one nucleotide sequence encoding the full hevein precursor 
prote in had been described so far: GenBank M3 698 6 (BROEKAERT et 
al., 1990, cited above). 
The 5' upstream region including the putative promoter sequences 
of two hevein genes has been released: GenBank AF327518 (DENG et 
al.); GenBank AF287016 (AROKIARAJ and JONES). 
However until now, nothing was known about the actual 
functionali ty and efficiency of the se sequences as promoters for 
driving the expression of heterologous genes. 
10 The inventors have now shown that the hevein precursors belong to 
a multigene family, that may be organized in two groups (group I 
and group II) based on nucleotide sequence homology. Further, the 
inventors have demonstrated that the 5' upstream region isolated 
from 3 different hevein genes, namely PHevl .1, representati ve of 
15 the hevein group I, and PHev2.1 (1824 bp) and PHev2.3 
(corresponding to AF287016) (966 bp), representatives of the 
hevein group II, are able to drive the expression of a transgene 
in Hevea. They are therefore functional as promoters. 
Additionally, the inventors have demonstrated that these promoters 
20 are also functional in rice, model plant for the monocots, and 
Arabidopsis, model plant for the dicots. Thus the promoter 
sequences from the various hevein genes may be used as promoters 
in transformation programs, not only in Hevea but also in various 
other heterologous systems. 
25 
Sununary of the Invention 
The first aspect of the present invention provides the shortest 
sequence shown by the inventors to be functional in Hevea as well 
30 as in rice is the PHevl.1 sequence. This sequence thus represents 
a promoter sequence able to drive the expression of a transgene in 
various plants, and consti tu tes a basis for the isolation of a 
longer promoter sequence, more readily usable as promoter in 
transformation programs. 
35 
5 
The second · aspect of the present invention provides the longest 
regulatory sequence tested by the inventors ( PHev2 .1) was 
demonstrated to be up-regulated by mechanical wounding in rice, 
with the capacity to respond systemically. It was also upregulated 
5 by pathogen infection. 
Further, the present invention provides the use of a 
polynucleotide selected among: 
(a) a polynucleotide having a sequence including nucleotides -
10 254 to -1 of the sequence of Figure 3 (nucleotides 1-254 of 
SEQ ID NO: 1); 
(b) a polynucleotide having a sequence including nucleotides -
448 to -1 of the sequence represented of Figure 4 
(nucleotides 1-448 of SEQ ID NO: 2); 
15 (c) a polynucleotide having a sequence including nucleotides -
1776 to -1 of the sequence of Figure 5, (nucleotides 1-1776 
of SEQ ID NO: 3); 
(d) a polynucleotide having a sequence including nucleotides -
1044 to -1 of the sequence of Figure 6, (nucleotides 1-1044 
20 of SEQ ID NO: 4); 
(e) a polynucleotide having a sequence including nucleotides -
919 to -1 of the sequence of Figure 7, (nucleotides 1-919 
of SEQ ID NO: 5; 
(f) a polynucleotide consisting of a fragment of at least 254 
25 bp from the 3'end of a polynucleotide (b) to (e); 
(g) a polynucleotide having at least 90% identity with a 
polynucleotide (a) to (f) and having a promoter function in 
a plant cell; as a promoter for driving the expression of 
an heterologous gene of interest in a plant. 
30 Advantageously, the polynucleotide (g) is selected among: 
a polynucleotide having at least 95% identity with any of 
the polynucleotides (a) or (b); 
a polynucleotide having at least 90% identity with any of 
the polynucléotides (c) to (f). 
35 According to a preferred embodiment of the invention, one will use 
a polynucleotide selected among; 
5 
10 
6 
(a') a polynucleotide of SEQ ID NO: 1; 
(b') a polynucleotide of SEQ ID NO: 2; 
(c') a polynucleotide of SEQ ID NO: 3; 
(d') a polynucleotide of SEQ ID NO: 4; 
( e') a polynucleotide of SEQ ID NO: 5; 
( f' ) a polynucleotide consisting of a fragment of at least 308 
bp from the 3'end of a polynucleotide (b') to (e'); 
(g') a polynucleotide having at least 90% identity with a 
polynucleotide (a') to (f') and having a promoter function 
in a plant cell. 
Preferably, said polynucleotide ( g') comprises a sequence having 
at least 95% identity with a 97 bp sequence immediately upstream 
the ATG of a polynucleotide (a) to (f). 
According to a preferred embodiment of the invention, a 
15 polynucleotide selected among: 
20 
- a polynucleotide (c) or (c')as defined above; 
- a polynucleotide (g) or (g')having at least 90% identity with 
said polynucleotide (c) is used as an inducible promoter 
regulated by wounds and pathogen infection. 
The present invention also provides a recombinant expression 
cassette comprising a promoter consisting of a polynucleotide (a) 
to (g), or preferably a polynucleotide (a') to (g') as defined 
above, and a heterologous polynucleotide placed under 
25 transcriptional control of said promoter. The term "heterologous 
polynucleotide" refers herein to any polynucleotide other than an 
hevein coding sequence. Said heterologous polynucleotide may 
consist for instance of a coding or of an antisense sequence of 
interest operably linked to said promoter, or of a cloning si te 
30 for inserting said sequence of interest. 
The present invention further provides recombinant expression 
vectors comprising an expression cassette of the invention. These 
expression vectors can be introduced into host cells and plants to 
35 produce transformed cells and transgenic plants, using rnethods 
7 
known in the art. Said transformed cells, in particular plant 
cells, and transgenic plants are also part of the invention. 
The present invention is sui table for use not only in Hevea and 
5 other plants of the euphorbeaceae family such as cassava or castor 
bean, but also in other dicotyledonous plants (as shown by the 
functionality of promoter sequences of the invention in the model 
plant Arabidopsis), including in particular plants producing latex 
such as guayule, sunflower, lettuce, dendelion or papaya. 
10 
Further, the present invention is also suitable for use in 
monocotyledonous plants, including in particular cereals, such as 
rice, maize, wheat, barley, or oats, and also including, in a non-
limitative way, other plants such as banana, sugar cane or palm 
15 trees. 
Brief Description of Figures 
Figure lA shows the synthetic oligonucleotide primers, starting 
20 with the primers T3, T7 and the reverse primer ORl, designed from 
the hevein cDNA sequence (GenBank accession M36986, position 58 to 
83) for the isolation of the hevein gene promoter region PHevl.l, 
PHevl.2, PHev2.1 and PHev2.2 
25 Figure lB shows the sequences of all the oligonucleotide primers 
used for the isolation and cloning of HevP (PHev2.3) 
Figure 2 shows the classification of the hevein genes and their 
subclones. Cloning I: genomic sequences including the full 
30 transcribed region and 5' upstream sequences of hevein genes, 
cloned in the pBlueScript phagemid from lambda Zap II 
(stratagene) Cloning II: Promoter regions isolated by PCR for Hev 
1.1, Hev 1.2, Hev2.1 and Hev2.2, subcloning from the pBS-Hev 
clones into the pGEMT-easy vector ( Promega) and Hev2. 3 (HevP), 
35 direct cloning by adaptor-anchored PCR in the pCR2 .1 TOPO vector 
(Invitrogen, USA). 
8 
Cloning III: Subcloning in a binary vector for transformation. For 
Hev2 .1 and Hev2. 2, isolated promoter reg ion cloned between the 
Hind III and Bgl II sites of the pCambia1381Z vector (Cambia). For 
Hev2. 3 (HevP), deleted fragments of the isolated promoter region 
5 cloned between the Xba I and Hind III sites of the pPGTV-KAN 
vector. 
10 
15 
20 
25 
Figure 3 shows the nucleotide sequence of the hevein 
reg ion Phevl. 1. The transcription start si te (A) 
translation initiation codon (ATG) are in bold letters. 
Figure 4 shows the nucleotide sequence of the hevein 
region Phevl. 2. The transcription start si te (A) 
translation initiation codon (ATG) are in bold letters. 
Figure 5 shows the nucleotide sequence of the hevein 
region Phev2 .1. The transcription start site (A) 
translation initiation codon (ATG) are in bold letters. 
Figure 6 shows the nucleotide sequence of the hevein 
reg ion Phev2. 2. The transcription start si te (A) 
translation initiation codon (ATG) are in bold letters. 
promoter 
and the 
promoter 
and the 
promoter 
and the 
promoter 
and the 
Figure 7 shows 
region Phev2. 3 
start si te (A) 
bold letters. 
the nucleotide sequence of the hevein promoter 
(HevP), isolated by nested PCR. The transcription 
and the translation initiation codon (ATG) are in 
Figure 8 shows the schematic diagram of the PCR-generated nested 
30 deletion fragments obtained from the hevein promoter region HevP 
(PHev2. 3) and cloned in pPGTV-KAN. The promoter sequences were 
joined to the uidA reporter gene. The 5' and 3' end points of the 
promoter sequences are numbered from the transcription start site 
of the hevein gene. 
35 
9 
Figure 9 shows the fluorometric analysis of the GUS activity in 
transgenic rice plants (Tl) carrying a single copy of the uidA 
gene driven by PHev2.1, in response to mechanical wounding. 
5 Figure 10 shows the results of fluorometric analysis of the GUS 
activity I transgenic rice plants (Tl) carrying a single copy of 
the uidA gene driven by PHev2.1, in response to fungal infection. 
10 
Detailed Description of Invention 
By way of example, the present invention 
tools for the genetic engineering of Hevea 
provides interesting 
wi th the purpose of 
improving existing genotypes for natural rubber production, or for 
molecular pharming. 
15 For instance, in Hevea genetic engineering programs, the use of a 
wound-inducible promoter will guaranty a high transgene expression 
level in the exploi ted bark tissues, owing to the regular wound 
stress imposed by tapping. This promoter will also be useful for 
increasing the expression of endogenous genes identified as 
20 limiting factors for the yield of latex production. The invention 
also allows to optimize transgene expression in the latex cells; 
this is of particular importance for programs of molecular 
pharming aiming at producing exogenous molecules of industrial 
interest in the latex. 
25 In a more general way, the present invention can be used in Hevea 
as well as in other plant systems, for improving the defenses of 
plants against biotic and abiotic stresses. The use of a promoter 
inducible by wounds and pathogen infection allows to over-express 
transgenes involved in defense, in situations such as aggressions 
30 by plant-eater insects or infection by microorganisms such as 
fungi. 
The present invention will be further illustrated by the 
additional description which follows, which refers to the 
isolation of the 5' upstream regions or several hevein genes and 
35 their use for expressing heterologous DNA in different plants. It 
should be understood however that these examples are given only by 
5 
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way of illustration of the invention and do not constitute in any 
way a limitation thereof. 
EXAMPLE 1: CLONING OF HEVEIN-ENCODING GENOMIC SEQUENCES AND 
ISOLATION OF THE 5' UPSTRE.AM REGION 
In Hevea, hevein is encoded by a small multigene family. We have 
isolated 5 different genomic sequences corresponding to hevein 
genes. Four sequences (Hevl.1, Hevl.2, Hev2.1 and Hev2.2) are 
10 including the full coding sequence of the hevein precursor as well 
as the 5' upstream region. One sequence includes the partial 
coding sequence and 5' upstream region of a fifth hevein gene 
(Hev2. 3). A partial sequence of Hev2. 3 is available in GenBank 
15 
under the accession AF287016. 
Cloning of Hevl.1, Hevl.2, Hev2.1 and Hev2.2 by library screening 
and isolation of the 5' upstream region 
Genomic library construction and screening: 
Genomic DNA was extracted from young leaves of Hevea brasiliensis 
20 cultivar RRIM600, using the method described by DELLAPORTA et al. 
( Plant genetic Transformation and Gene Expression. A laboratory 
Manual, (Draper,J., Scott,R., Armirage,P., Walden,R. eds), pp.214-
216, Blackwell Scientific, London, UK, 1985). 
25 
A genomic library was constructed by 
genomic DNA to the EcoR I site of 
ligating 
the Lambda 
EcoR 
Zap 
I-digested 
II vector 
(Stratagene). Phages were packaged using the Stratagene "Gigapack 
III Gold Packaging extract" and plated in the hast strain XLl-
blue MRF', as described by the manufacturer. Two rounds of 
screening were performed using a 1 kb cDNA probe corresponding to 
30 the full length hevein cDNA (BROKAERT et al., 1990, cited above). 
Hybridization was performed overnight at 65 ° C, in 5 x SSC ( 0. 3 M 
NaCl, 30 mM trisodium-citrate, pH 7), lOx Denhardt's reagent (0.2% 
ficoll, 0.2% PVP, 0.2% BSA), 7% SDS, 20 mM sodium phosphate buffer 
pH 7.2 and 100 µg ml-1 denatured salmon sperm DNA. Final washes 
35 were carried out at 65 °C, in O .1 x SSC and O. 5% SDS. From the 
5 
selected phage colonies, 
11 
the pBlue-Script SK (-) phagemids 
containing the cloned genomic inserts were excised by cc-infection 
wi th the ExAssist helper phage and transferred into E. coli XLl 
blue. The excised phagemids were extracted using Quiagen kits and 
mapping was performed using the enzymes KpnI, EcoRI, SacI, 
HindIII, PstI and XhoI, in TA buffer (33 rnM Tris acetate pH 7. 9, 
60 mM K+ acetate, 10 rnM Mg2+ acetate, 0.5 rnM OTT and 0.1 mg/ml of 
BSA, added extemporarily) , at 37°c. The restriction fragments, 
separated by electrophoresis in 0.8% agarose gel, were transferred 
10 onto nylon membranes and analyzed by Southern hybridization, to 
determine the orientation of the hevein gene inside the cloning 
vector. Two probes were used successively: a cDNA fragment located 
near the 5' terminus of the cDNA (GenBank accession M36986, 
position 1-91), and the last 339 bp of the cDNA, including the 
15 whole 3' non coding reg ion. 
Four clones differing in restriction map were selected and 
sequenced on both strands using synthetic oligonucleotide primers, 
starting with the primers T3, T7 and the reverse primer ORl, 
. 
designed from the hevein cDNA sequence (GenBank accession M36986, 
20 position 58 to 83). These primers are shown in Figure lA. 
25 
Then new primers were designed successively from each new sequence 
obtained. The four clones were named pBS-Hevl.1, pBS-Hevl.2, pBS-
Hev2.1 and pBS-Hev2.2. 
Subcloning I: 
Phagemids pBS-Hevl.1 and pBS-Hev2.l, were chosen for PCR 
amplification of the hevein gene 5' upstream reg ion. The forward 
primer SCH-S2 (Fig. lA) was designed from the pBlue-Script SK 
phagemid vector, 12 bp from the T3 promoter. The reverse primer 
SCH-R2 (Fig. lA) was designed from the hevein gene upstream 
30 sequence PHev2 .1, at position +27 to +48 from the transcription 
start site, 6 bp upstream the ATG described by BROEKAERT et al. 
(1990, cited above) as the translation initiation codon. 
Amplification was performed in a Perkin Elmer thermocycler, in a 
50 µl final volume, using 2 ng of .KpnI-linearized phagemid as 
35 matrix, and DNA polymerase mix and buffer from the "Expand High 
Fidelity PCR System" (Boehringer), supplemented with MgC12 (3 rnM) • 
5 
10 
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Amplification was performed over 35 cycles under the following 
conditions: denaturation at 94°C for 45 sec, annealing at 50°C for 
45 sec and elongation at 72 °C for 2 min. The PCR fragments were 
purified by electrophoresis 
eluted on affinity columns 
in 1. 2% low melting agarose gel and 
(NUCLEOSPIN Extract, Macherey-Nagel) 
and ligated in pGEM-T easy vector (Promega). 
The new constructs, named pGEMT-PHevl.1 and pGEMT-PHev2.1 (Fig. 2) 
were introduced into E Coli DH5a bacteria by electroporation. 
Subcloning II: 
The plasmid pCAMBIA 13812 (CAMBIA) 
enzymes HindIII and Bgl II in buffer 
then dephosphorylated using alkaline 
Mannheim). 
was restricted using the 
II (Boehringer Mannheim) , 
phosphatase AP (Boehringer 
The plasmids pGEMT-PHevl.1 and pGEMT-PHev2.1 were restricted using 
15 the enzymes HindIII and BglII in buffer II (Boehringer Mannheim). 
The fragments corresponding to the promoter regions were isolated 
on 1.2% low melting agarose gel and purified using NUCLEOSPIN 
Extract columns (Macherey-Nagel). They were ligated into the 
HindIII/BglII-restricted and dephosphorylated vector pCAMBIA 
20 13812. The new constructs, named pCAMBIA-PHevl.1 and pCAMBIA-
PHev2 .1 (Fig. 2) , were introduced into Agrobacteria ( strain LBA 
4404) by electroporation. The constructs were re-extracted from 
the Agrobacterium using QIAGEN plasmid extraction system and 
checked by restriction profile analysis using the enzymes XhoI and 
25 Eco RV and by sequencing. 
The four clones isolated (Hevl.1, Hevl.2, Hev2.1 and Hev2.2), 
include the full transcribed region of four different hevein 
genes, together with about 300 to 1. 8 kb of their 5' upstream 
sequence. 
30 They were classified in 2 groups based on nucleotide sequence 
homology. The members of group I (Hev 1.1 and Hev 1.2) share about 
96% identity while the members of group II (Hev2 .1 and Hev2. 2) 
share 99% identity. The percentage of identity between members of 
the two different groups is about 86%. 
35 
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Cloning of HevP (PHev2.3) by adaptor-anchored PCR and subcloning. 
A fifth clone (HevP, or PHev2.3) including the leader peptide and 
5' flanking reg ion of another hevein gen_e (Hev2. 3) belonging to 
the hevein group II gene family, was isolated by adaptor-anchored 
5 PCR. 
High-molecular weight DNA was isolated from young leaves of RRIM 
600 (Hevea brasiliensis) using the method as described by 
DELLAPORTA et al. (1985, cited above). Genomic mini-libraries were 
constructed using the Hevea genomic DNA by using the Universal 
10 GenomeWalker™ Kit according to manufacturer' s instructions 
(Clontech Laboratories, Inc, CA, USA). The mini-libraries were 
used as template DNA for PCR and nested PCR reactions for the 
isolation of hevein upstream sequences. The oligonucleotide 
primers were synthesized by Operon (Operon Technologies Inc, USA). 
15 The sequences of all the oligonucleotide primers used are listed 
in Figure lB. 
Primary PCR reaction: 
DNA .amplification was carried out on a thermal cycler, in a 50 µl 
volume, containing 5 µlof lOx Tth PCR reaction buffer (Clontech), 
20 2.2 µlof 25mM Mg(OAc) 2 , 1 µlof 10 µM of each primer (GSP3 hevein 
and APl), 1 µlof 10 mM each dNTPs, 1 µlof Advantage Polymerase 
Mix (2. 5 units) (Clontech), 1 µl of the genomic mini libraries and 
37.8 µlof deionised H20. Using a two-step cycle parameter in a DNA 
Thermal Cycler 4 8 0 ( PE Biosystems) the PCR reaction was carried 
25 out as follows: 7 cycles at 94°C for 25 sec and 72°C for 3 min; 32 
cycles at 94°C for 25 sec and 67°C for 3 min; 67°C for an 
addi tional 7 min after the final cycle. Eight micro li ters of the 
primary PCR product were analyzed on a 1.5% agarose gel along with 
DNA size marker (Gibco BRL 1 kb Plus Ladder). 
30 Secondary PCR reaction: 
A secondary PCR reaction was performed using a 1: 50 dilution of 
the primary PCR product. DNA amplification was carried out on a 
thermal cycler, in a 50 µl volume, containing 5µ1 of lOx Tth PCR 
reaction buffer (Clontech), 2.2 µlof 25 mM Mg(OAc) 2 , 1 µlof 10 µM 
35 of each primer (GSP2 hevein and AP2), 1 µl of 10 mM each dNTPs, 
1 µl of Advantage Polymerase Mix (2. 5 units) (Clontech), 1 µl of 
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the diluted (1:50) primary PCR product as template DNA and 37.8 µl 
of deionised H20. Using a two-step cycle parameter in a DNA Thermal 
Cycler 480 (PE Biosystems) the PCR reaction was carried out as 
follows: 5 cycles at 94°C for 25 sec and 72°C for 3 min; 20 cycles 
5 at 94°C for 25 sec and 67°C for 3 min; 67°C for an additional 7 
min. after the final cycle. 
Five microliters of the secondary PCR products were analyzed on a 
1. 5% agarose gel, along DNA size marker (Gibco BRL 1 kb Plus 
Ladder). The amplified product (1.3 kb) was excised from the gel 
10 and purified. The purified DNA fragment was cloned into TOPO 
Cloning TA vector pCR®2.1TOPO® (Invitrogen, USA) and transformed in 
E. Coli DHSa. Plasmid extractions were performed using the Qiagen 
Plasmid Mini Kit (Qiagen Inc, USA). The 1.3 kb insert was released 
by restriction using the enzyme EcoR I, then sequenced 
15 (Strathclyde University, Department of Molecular Biology, United 
Kingdom) using as primers, M13R and M13F. 
Comparison of the promoter sequences of the hevein genes 
The transcription start site was identified by primer extension 
2 0 from the clone PHev2. 3, and deduced by sequence homology for the 
others. It is located 54 nt upstream the ATG codon described as 
the hevein mRNA translation start point. 
The 5' upstream sequences of the fi ve hevein genes are presented 
in Figures 3 (PHevl.l.), 4 (PHevl.2.), 5 (PHev2.l.), 6 
25 (PHev2. 2.) and 7 (PHev2. 3.). The transcription start site (A) and 
translation initiation codon (ATG) are in bold letters. 
The 5' upstream regions of the 5 sequences PHevl.1, PHevl.2, 
PHev2.l, PHev2.2 and PHev2.3 were aligned together with a sequence 
released in the GenBank public database under the accession number 
3 0 AF 3 2 7 518 . 
All six promoter sequences are highly homologous (96% identity) 
over a 97 bp sequence immediately upstream the ATG (beginning at 
position -40 from the transcription start site). Further upstream, 
the sequences diverge in two different groups, with 39-43% 
35 identity only between members of the 2 groups. A high sequence 
homology is conserved among each group, with about 97% identity 
15 
shared by members of group I ( PHevl .1 and PHevl. 2) and 94-98% 
identity shared by members of group II (PHev2.1, PHev2.2, PHev2.3 
and AF327518 ) . PHev2.3, although clearly belonging to group II, 
lacks a 30 bp domain located at position -173-143 from the 
5 transcription start site, when compared · to PHev2 .1, PHev2. 2 and 
AF327518 . 
EXAMPLE 2: FUNCTIONAL ANALYSIS IN HEVEA 
10 Deletion fragments from HevP (PHev2.3). 
The clone HevP (PHev2. 3) was deleted to generate 4 overlapping 
fragments of decreasing length in the upstream region. 
PCR generated fragments of hevein upstream region were derived 
from the HevP clone using as primers Hev PF, Hev Pl, Hev P2, Hev 
15 P3 and Hev P4 (Fig. lB) following routine PCR protocol (HAMILL et 
al., Plant Cell Rep. 10, 221-22 4, 1991) . The amplified fragments 
were double digested with XbaI/HindIII, then purified and ligated 
to gGPTV-KAN (BECKER et al., Plant Mol. Biol. 20, 1195-1197, 1992) 
digested with XbaI/HindIII and dephosphorylated. 
20 The binary vector pGPTV-KAN contains unique cloning sites upstream 
of the uidA gene which allows the insertion of promoter fragments. 
The T-DNA nopaline synthase (pAnos) and gene 7 (pAg7) poly (A) 
signals follow the uidA gene and the selectable marker (nptII) 
genes, respectively. 
25 In the four constructs generated (pGPTV-KAN-1, pGPTV-KAN-2, pGPTV-
KAN-3 and pGPTV-KAN-4), the hevein upstream fragments are fused to 
the uidA gene. The correct orientation and sequence of the fusions 
were verified. 
A schematic diagram of these constructs is represented in Figure 
30 8. The 5' and 3' end points of the promoter sequences are numbered 
from the transcription start of the Hevein gene. pGPTV-KAN-1(-275 
to +55); pGPTV-KAN-2 (-389 to +55); pGPTV-KAN-3 (-687 to +55) and 
pGTV-KAN-4 (-919 to +55). Arrows indicate direction of 
transcription; R, right TDNA border; L, left T-DNA border. 
35 Abbreviations: St=SstI, E=EcoRI, Sm=SmaI, X=XbaI, S=SalI, 
,.. 
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H=HindIII, B=BgIII, Bm=BamHI, npt II=neomycin phosphotransferase 
II gene. 
The 4 constructs generated (pGPTV-KAN-1; pGPTV-KAN-2; pGPTV-KAN-3; 
pGPTV-KAN-4), together with pCAMBIA2301 as positive control, were 
5 transferred into Agrobacterium tumefaciens GV2260 by 
electroporation (SHEN and BRIAN, Nucleic Acid Research 17, 8395, 
1989). The Hevea brasiliensis cultivar GLl was transformed using 
the Agrobacterium tumefaciens-mediated protocol described by 
AROKIARAJ et al. (1998, cited above) 
10 The transformed cells, selected on kanamycin for about 2 months, 
were then screened for GUS expression by histochemical staining. 
GUS activity is indicated by a blue coloration after incubation 
with X-Glue. 
The calli carrying the various hevein promoter constructs and 
15 positive control pCAMBIA2 301 displayed a blue colored surface, 
whereas this was not observed in the negative control sample. The 
same coloration was observed also in embryoids for all constructs 
except the negative control sample . 
. 
These results demonstrate that the various fragments isolated from 
20 the hevein PHev2.3 upstream regulatory sequence, from the longest 
(position -919 to +55) to the shortest (position -276 to +55), are 
able to drive the transcription of the uidA reporter gene in Hevea 
callus and embryoids. 
2 5 PHevl . 1 and PHev2 . 1 
The constructs pCAMBIA-PHevl.1 and pCAMBIA-PHev2.1, containing 
respectively about O. 3 kb and 1. 8 kb of the upstream sequence of 
Hevl .1 and Hev2 .1 (hevein genes representati ve of group I and II 
respectively) fused to the uidA reporter gene, were introduced 
30 into inner integument-derived Hevea callus, by microprojectile 
bombardment-mediated transformation, to verify their 
functionality. 
The cultivar RRIM 600 was transiently transformed by 
microproj ectile bombardment of cal lus ini tiated from inner 
35 integument and maintained as described by CARRON et al. 
(Biotechnology in Agricul tural and Forestry, (Baj aj, Y. P.S. ed) , 
17 
pp 353-369, Springer Verlag, Berlin Heidelberg, 1995). The 
particle gun was from BIORAD and the transformation procedure was 
as described by the manufacturer, with a 1100 psi rupture 
membrane. The distance between the rupture membrane and the macro-
s carrier was 6 cm. The distance between the macro-carrier and. the 
callus was 6 cm. 
Transient expression analysis via histochemical GUS staining 
revealed spots of blue cells for both constructs, demonstrating 
that the isolated PHevl .1 and PHev2 .1 upstream regulatory 
10 sequences are able to drive the expression of the uidA reporter 
gene in Hevea callus. 
EXAMPLE 3: FUNCTIONAL ANALYSIS IN RICE 
15 The constructs pCAMBIA-PHevl.1 and pCAMBIA-PHev2.1 were introduced 
in rice, model plant for the monocots, via Agrobacterium-mediated 
transformation. The pCAMBIA-1301 vector, bearing the uidA gene 
fuse? to the CaMV 35S promoter, was used as control. 
The rice cultivar Nipponbare (Japonica) was transformed via 
20 Agrobacterium tumefaciens following the procedure described by 
SALLAUD et al. (Theoritical and Applied Genetics, in press). 
Dehulled mature seeds were sterilized and incubated on NB medium 
in the dark, as described in CHEN et al. ( Plant Cell Rep. 18, 25-
31, 1998), for the production of nodular callus units. Selected 
25 units (3-5. mm) were immersed for 10-15 min. in an Agrobacterium 
suspension (00 600 of 1) in CCL liquid cc-culture medium (R2 medium 
from OHIRA et al., Plant Cell Physiol. 14, 1113-1121, 1973; 
supplemented with 2.5 mg/1 2,4-D, 10 g/1 glucose, 100 µM 
acetosyringone, pH 5. 2), then blotted dry and transferred onto 
30 solid cc-culture medium (CCL with 7 g/1 agarose). After 3 days at 
25 °C in the dark, the calli were transferred to R2S selection 
medium (R2 medium containing 30 g/1 glucose, 50 mg/1 hygromycin, 
400 mg/1 cefotaxime, 100 mg/1 vancomycine, 7 g/1 agarose, pH6. 0), 
at 27 °C in the dark. After 2 weeks of selection, the calli were 
35 transferred to NBS medium (NB basic supplemented with 2. 5 rng/1 
2,4-D, 500 rng/1 praline, 500 mg/1 glutamine, 300 rng/1 casein 
hydrolysa te, 
vancomycine, 
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50 mg/1 hygromycin, 400 mg/1 
7 g/1 agarose, pH6.0): The 
cefotaxime, 
resistant 
100 mg/1 
globular 
structures developed from the brownishing callus 
and incubated for 10-15 days on fresh NBS medium, 
were separated 
then placed on 
5 PRAG pre-regeneration medium (NB basic supplemented with 2 mg/1 
BAP, 1 mg/1 NAA, 5 mg/1 ABA, 500 mg/1 praline, 500 mg/1 glutamine, 
300 mg/1 casein nydrolysate, 50 mg/1 hygromycin, 100 mg/1 
cefotaxime and 100 mg/1 vancomycine, 7 g/1 agarose, pH5.8), for 
one week. Creamy_white lobed calli were transferred to RN 
10 regeneration medium (NB basic supplemented with 3 mg/1 BAP, 
0.5 mg/1 NAA, 30 g/1 glucose, 50 mg/1 hygromycin, 4.5 g/1 
Phytagel, pH5.8), for 2 days in the dark then for 3 weeks with a 
12 hours photoperiod. Shoots regenerating from a resistant callus 
were subcultured in test tubes containing MS medium (MURASHIGE and 
15 SKOOG, Physiol. Plant 15, 473-497, 1962) with 50 g/1 glucose, 
2. 6 g /1 Phytagel, pHS. 8. After 3 weeks, the y were transferred to 
Jiffy peat pellets for 15 days, then to soil pots in the 
greenhouse. 
20 
Only the hygromycin-resistant 
insertion were selected, by 
analysis. 
plants presenting a 
Southern blotting, 
single T-DNA 
for further 
Histochemical analyses of ~-glucuronidase (GUS) activity were 
performed as described by JEFFERSON et al. (EMBO J. 6(13), 3901-
3907, 1987), on a) basal section of an unwounded leaf; b) 
25 section of a leaf wounded with needles; c) root; d) immature seed 
with pollen bags; e) longitudinal section of an immature seed; f) 
immature flower; g) pollen grains. 
In case of the longest prornoter sequence (PHev2 .1), blue 
colorat·ion after incubation with X-Glue was observed in wounded 
30 leaf tissues ( eut hedge or needle impacts) , for all of the 8 
plants analyzed, demonstrating that the PHev2.1 sequence is 
functional as a promoter and potentially wound-inducible in rice. 
In roots, blue coloration was observed in the vascular tissue, for 
all plants tested but in some of the roots only. In the floral 
35 tissue, a strong coloration was observed in the pollen bags and in 
5-10% of the pollen grains. Patches of coloration were frequently 
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observed on the lernrna and palea, on the seed tegument, and 
occasionally in the scutellum. 
In case of PHevl.l, GUS activity was detected for some of the 
plants only (5 plants out of 9), in wounded leaf tissues and in 
5 root vascular tissues. In the flowers and grains, the coloration 
was limited to the lernrna and palea. 
Histochemical analysis of GUS activity in plants of first 
generation (TO) demonstrates that both constructs are functional 
in such heterologous system. 
10 Fluorimetrical analyses were performed as described by JEFFERSON 
et al. (1987, cited above). Explants were frozen in liquid 
nitrogen and stored at -80°C. Total soluble proteins were 
extracted by grinding 200 mg of explant in 500 µl extraction 
buffer (50 rnM Tris-HCl pH 8, 1 rnM EDTA pH 8, 5% v/v glycerol, lrnM 
15 DTT, 0.1% v/v Triton). After centrifugation at 20000 g for 15 min 
at 4°C, the supernatant was collected and centrifuged again for 5 
min in the same conditions. Proteins from the supernatant were 
quantified (Bradford, 1976) using a Multiscan RC (Labsystems) 
spectrophotometer, coupled to the software Genesis version 2. 00 
20 (Labsystems). The fluorescence of 4-MU (4-methylumbelliferone) 
generated after cleavage of the 4-MUG ( 4-methylumbelliferyl B-D-
glucuronic acid) substrate by the GUS enzyme, was measured at 460 
nm using the fluorimeter "Fluoroscan II version 6. 3 (Labsystems)" 
coupled to the software Genesis version 2.00. 
25 Fluorimetrical analysis revealed that the GUS activity was much 
higher in plants bearing PHev2 .1 than in plants bearing PHevl .1 
(with an average value of 243 against 11 pmol MU/min/µg of 
proteins, in Tl plants), owing probably to the difference in size 
of the two promoter regions. Moreover, all the PHev2 .1-carrying 
30 plants tested (8/8) expressed the uidA gene, whereas for the 
PHevl.1-carrying plants, GUS activity was measurable by 
fluorimetry for 2 plants only, out 9 tested. The GUS acti vi ty 
measured in Tl plants carrying the CaMV 35S promoter was 470 pmol 
MU/min/µg of proteins in average. Therefore, it appears that the 
35 strength of the 1.8 kb PHev2.1 promoter region is about half that 
of the 35S promoter, in normal conditions. 
20 
Assays of the inducibili ty of PHevl. 1 and PHev2. 1 in transgenic 
rice. 
TO transgenic plants presenting a single T-DNA insertion, as 
5 determined by Southern blot analysis, were transferred to the 
green house and grown for seed production (Tl population) . The 
growth conditions were strictly controlled: 25°C, 75% humidity and 
11 h 30 min under artificial light (400 µmolE.m-2.s- 1 ). Seeds were 
collected and dried at 37°C for 3 days, then kept at room 
10 temperature. For the selection of hygromycin-resistant Tl lines 
(transformed plants of second generation), seeds were surface-
sterilized and placed in a Petri dish on Whatman paper soaked with 
50µg.mr 1 hygromycin. After five to seven days, germinated seeds 
were transferred to the green house. 
15 Tests were performed on 4-5 weeks old seedlings. Each transgenic 
line was represented by 3 Tl progenies in each condition. 
Fluorometric analyzes were performed on full leaves, to avoid 
artifacts linked to the possible existence of a gradient of 
expression of the hevein promoter along the leaves. 
20 Mechanical Wounding: 
The regulation of the hevein promoters by mechanical wounding was 
verified by fluorimetrical analysis. Mechanical wounding was 
performed by pricking wi th needles the whole surface of the last 
fully developed leaf. Four different transgenic lines bearing the 
25 PHev2.1 promoter region were analyzed. For each line, 7 batches of 
3 Tl plants were used. For one batch (T 0 ), the last fully developed 
leaf was collected, before any wounding. Five other batches (T1 , 
T3 , T6 , T10 and T2 4) were submitted to mechanical wounding by 
pricking with needles the whole limb surface of the last fully 
30 developed leaf, then the wounded leaves were collected 
respectively 1, 3, 6, 10 and 24 hours after wounding. For the last 
batch (T10S) , the first and third leaves were wounded, then the 
intermediary unwounded leaf was collected 10 hours after wounding, 
in order to test for systemic induction in response to wounding. 
35 The results are shown in Figure 9: for each time point, the GUS 
activity value represented is the average value from 4 different 
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transgenic lines, each line being represented by the average value 
from 3 Tl progenies. 
All four lines bearing the PHev2 .1 promoter region displayed a 
significant overexpression of the uidA gene in response to 
5 wounding, with maximum amplitude observed 10 hours after wounding 
(amplification factor 1.4 to 1.6). This induction was 
statistically highly significant ( P<O. 01) as evaluated by Fisher 
test (LSD) .No significant change was observed for the plants 
bearing the CaMV 35S promoter. The level of activity of the wound-
10 stimulated PHev2.1 promoter is thus very close (80%) to the level 
displayed by the 35S promoter in similar conditions. Moreover, the 
PHev2 .1 promoter appeared to respond also systemically to 
wounding. The amplification factor measured on· intact leaves 
framed by wounded leaves 10 hours after wounding was about 1.2 in 
15 average. 
For the only two lines expressing the uidA gene driven by the 
short promoter region PHevl.1, no modification of the GUS activity 
in response to wounding could be measured, the expression level 
being two low. 
2 0 Inocula tian by pa thogens: 
Six transgenic lines, represented by 3 batches of 3 Tl progenies, 
were analyzed. For each line, one batch was inoculated with spores 
(100 000 per ml, in 0.5% gelatin) from the fungus Magnaporthe 
grisea strain TH16 which generates pyriculariose symptoms of 
25 medium severity on the rice variety Nipponbare. One full leaf was 
collected for analysis 4 days after inoculation (I 4 ). The two other 
batches were sprayed with 0.5% gelatin only and one full leaf per 
plant was collected for analysis, either immediately (Co) or 4 days 
after treatment (C 4 ). 
30 The results of fluorimetrical analysis are shown in Figure 10; for 
each event, the GUS activity value represented is the average 
value from 6 different transgenic lines, each line being 
represented by the average value from 3 Tl progenies. 
The se resul ts show that the inoculation wi th Magnaporthe grisea 
35 (strain TH16), agent of the rice pyriculariose, triggers a 
significant activation of the PHev2.1 promoter. This was observed 
5 
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for all 6 transgenic lines tested, with amplification factors 
comprised between 1. 2 and 1. 4. This induction was statistically 
highly significant (P<0.01) as evaluated by Fisher test (LSD). 
EXAMPLE 4 FUNCTIONAL ANALYSIS IN ARABIDOPSIS 
Arabidopsis thaliana ( ecotype ColO) was transformed in planta as 
described by Clough and Bent (1998). Seeds were collected and 
stored at 4°C, at least for one week, for vernalisation. Selection 
10 of the transgenic events was performed as follows: seed were 
sterilized for 20 min in a mixture of 30% sodium hypochlorite, 
absolute ethanol and water (1/4/3; v/v/v), rinsed three times with 
absolute ethanol and dried for 2 hours. They were then sown and 
grown in vitro on MS/2 medium supplemented with 30 µg .mr1 
15 hygromycin. The hygromycin resistant seedlings (transformed events 
of first generation, or TO) were transferred to the green house 
after development of the first leaves. Transformed lines of second 
genexation (Tl) were similarly selected on hygromycin. 
Arabidopsis plantlets bearing the uidA gene dri ven by 
20 the PHev2.1 promoter sequence were grown in vitro on medium 
containing hygromycin then tested histochemically for GUS 
activity. Blue coloration revealing GUS activity was observed in 
about 65% (17/26) of the hygromycin-resistant lines, in all parts 
of the plants, both in TO plants and their hygromycin-selected Tl 
25 progenies, demonstrating that the promoter sequence PHev2.1 can be 
functional in such heterologous system. Fo;i:- the others ( 35%) , no 
blue coloration was observed. 
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CLAIMS 
1) The use of a polynucleotide selected among: 
(a) a polynucleotide having a sequence including nucleotides -
5 254 to -1 of the sequence of Figure 3 (nucleotides 1-254 of 
SEQ ID NO: 1); 
(b) a polynucleotide having a sequence including nucleotides -
448 to -1 of the sequence represented of Figure 4 
(nucleotides 1-448 of SEQ ID NO: 2); 
10 (c) a polynucleotide having a sequence including nucleotides -
· 1776 to -1 of the sequence of Figure 5, (nucleotides 1-1776 
of SEQ ID NO: 3); 
(d) a polynucleotide having a sequence including nucleotides -
1044 to -1 of the sequence of Figure 6, (nucleotides 1-1044 
15 of SEQ ID NO: 4); 
(e) a polynucleotide having a sequence including nucleotides -
919 to -1 of the sequence of Figure 7, (nucleotides 1-919 
of SEQ ID NO: 5; 
(f) a polynucleotide consisting of a fragment of at least 254 
20 bp from the 3'end of a polynucleotide (b) to (e); 
(g) a polynucleotide having at least 90% identity with a 
polynucleotide (a) to (f) and having a promoter function in 
a plant cell; 
as a promoter for dri ving the expression of an heterologous gene 
25 of interest in a plant or a plant cell. 
2) The use of claim 1, wherein said polynucleotide is selected 
among 
- a polynucleotide (c) as defined in claim 1; 
30 - a polynucleotide (g) having least 90% identity with said 
polynucleotide (c) and is used as an inducible promoter 
regulated by wounds and pathogen infection. 
35 
3) A recombinant expression 
consisting of a polynucleotide 
cassette comprising a promoter 
(a) to (g) as defined in any of 
24 
claims 1 or 2, and a heterologous polynucleotide placed under 
transcriptional control of said promoter. 
4) A recombinant expression vectors comprising an expression 
5 cassette of claim 3. 
5) A transformed cell comprising an expression cassette of claim 
3. 
10 6) A transgenic plant comprising an expression cassette of claim 
3. 
7) A transgenic plant of claim 6, wherein said plant is a 
dicotyledonous. 
15 
8) A transgenic plant of claim 7, wherein said plant is Hevea 
brasiliensis. 
9) A transgenic plant of claim 6, wherein said plant is a 
20 monocotyledonous. 
25 
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ABSTRACT 
PROMOTER SEQUENCES FROM HEVEA BRASILIENSIS HEVEIN GENES 
The present invention relates to the isolation of DNA sequences 
5 from the Hevea brasiliensis containing the promoter and regulatory 
region of hevein genes, and to demonstrate their functionality in 
Hevea as well as in heterologous systems. The present invention 
also provides a recombinant expression cassette comprising the 
hevein promoter and a heterologous polynucleotide placed under 
10 transcriptional control of said promoter. The present invention 
further provides recombinant expression vectors comprising an 
expression cassette of the invention, introduced into host cells 
and plants to produce transformed cells and transgenic plants. For 
that purpose, chimaeric gene constructs containing hevein 5' 
15 flanking DNA linked to the uidA reporter gene was prepared and 
introduced into Hevea callus, and for some of the constructs, in 
model plants (rice or Arabidopsis). Functional analysis conducted 
by histochemical analysis and by measuring the ~-glucuronidase 
enzyme activity, in various contexts revealed the functionality of 
20 the hevein promoter in transformed cells and transgenic plants. 
25 
30 
The promoter sequences of the hevein genes also acts as an 
inducible promoter regulated by wounds and pathogen infection. 
26 
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Primer name and position Primer sequence 
T3 5' ATTAACCCTCACTAAAGGGA 3' (SEQ ID NO: 6) 
T7 5' TAATACGACTCACTATAGGG 3' (SEQ ID NO: 7) 
ORl : Hevein, + 128 to + 103 (FIG. 5) 5' CCTGCTTGCCGACCACATTGCTCAGC 3' (SEQ ID NO: 8) 
SCH-S2: pBlueScript SK 5' AACAGCTATGACCATGATTAC 3' (SEQ ID NO: 9) 
SCH-R2: Hevein +48 to +27 (FIG. 5) 5' TCAGATCTCCCA TTTCTTCCCAA TTCTTG 3' (SEQ ID NO: 10) 
Bglll 
15 FIGURE lA. Oligonucleotides used in polymerase chain reaction (PCR) on sequencing, for the 
isolation of the hevein gene promoter region PHevl.1, PHevl.2, PHev2.1, PHev2.2. Restriction 
enzyme site is underlined. ORl is hevein-specific primer designed from the cDNA coding 
sequences (GeneBank M36986), close to the translation initiation codon. The position is numbered 
from the transcription start site. 
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Primer name and position Primer sequence 
GSPI hevein: + 174 to + 145 (FIG. 7) 5' CTGGCTACAACATAGGTTATTGGGGCAGAG 3' (SEQ ID NO: II) 
GSP2 hevein: + 185 to + 159 (FIG. 7) 5' GTGGAGCCACACCACCCCCACTGGCTA 3' (SEQ ID NO: 12) 
GSP3 hevein: +205 to + 176 (FIG. 7) 5' CAGGTGAACAATATTCATCAGTGGAGCCAC 3' (SEQ ID NO: 13) 
API Genome Walker Adaptor (CLONTECH) 5' GTAATACGACTCACTATAGGGC 3' (SEQ ID NO: 14) 
AP2 Genome Walker Adaptor (CLONTECH) 5' ACTATAGGGCACGCGTGGT 3' (SEQ ID NO: 15) 
Xbal 
Hev PF: +55 to +72 (FIG. 7) 5' GGTCTAGACCCATTTCTTCCCAATTC 3' (SEQ ID NO: 16) 
Hind!II 
Hev Pl: -275 to -258 (FIG. 7) 5' GGAAGCTTCCTGGCCCTATGCTCTAT 3' (SEQ ID NO: 17) 
Hind!II 
Hev P2: -389 to -372 (FIG. 7) 5' GGAAGCTTCGAGTTAACCCTTGCGTT 3' (SEQ ID NO: 18) 
Hind!II 
Hev P3: -687 to --670 (FIG. 7) 5' GGAAGCTTGCCCTCTTGGTTGTTGCC 3' (SEQ ID NO: 19) 
Hind!II 
. 
Hev P4: -919 to -903 (FIG. 7) 5' GGAAGCTTCGACGGCCCGGGCTGGT 3' (SEQ ID NO: 20) 
M13 Fotward 5' GTAAAACGACGGCCAG 3' (SEQ ID NO: 21) 
Ml3 Reverse 5' CAGGAAACAGCTATGAC 3' (SEQ ID NO: 22) 
SMART III (CLONTECH) 5'AAGCAGTGGTATCAACGCAGAGTGGCCATTATGGCCGGG3' 
(SEQ ID NO : 23) 
CDS III/3' PCRPrimer (CLONTECH) 5' ATTCTAGAGGCCGAGGCGGCCGACATG-d(T)30N_1N 3' 
(SEQ ID NO: 24) 
5'PCR Primer (CLONTECH) 5' AAGCAGTGGTATCAACGCAGAGT 3' (SEQ ID NO: 25) 
SI (Gus Fusion Junction) 5' GATTTCACGGGTTGGGGTTTCT 3' (SEQ ID NO: 26) 
FIGURE lB. Oligonucleotides used in the polymerase chain reaction (PCR) or sequencing, for the 
isolation of the hevein gene promoter region HevP. Restriction enzyme sites are underlined. GSPI, 
GSP2, GSP3 are hevein-specific primers designed from the cDNA coding sequences Their position 
5 is numbered from the transcription start site. 
28 
Genename Sequence homology Cloning I Cloning Il Cloning III / insert size 
group ( full length gene) (isolated upstream (in binary vector) 
region) 
Hevl.1 GroupI pBS-Hevl.1 pGEMT-PHevl .1 pCambia-PHevl .1 / 303 bp 
Hevl.2 pBS-Hevl.2 pGEMT-PHevl .2 
Hev2.1 Group II pBS-Hev2.1 pGEMT-PHev2.1 pCambia-PHev2. l / 1824 bp 
Hev2.2 pBS-Hev2.l pGEMT-PHev2.l 
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Hev2.3 
(HevP) 
Group II 
5 FIGURE 2. Classification of the hevein genes and their subclones. 
PCR2.1 TOPO-HevP pPGTV-KAN-1 
pPGTV-KAN-2 
pPGTV-KAN-3 
QPGTV-KAN-4 
/ 323 bp 
/ 436bp 
/ 734 bp 
/ 966bg 
Cloning I: genomic sequences including the full transcribed region and 5' upstream sequence of hevein genes, cloned in the pBlueScript 
phagemid from lambda Zap II (Stratagene ). 
Cloning II: Promoter regions isolated by PCR. For Hevl.l, Hevl.2, Hev2.l and Hev2.2, subcloning from the PBS-Hev clones in the pGEMT-
easy vector (Promega). For Hev2.3 (HevP), direct cloning by adaptor-anchored PCR in the pCR2. l TOPO vector (Invitrogen, USA). 
1 O Cloning III: Subcloning in a binary vector for transformation. For Hev2.1 and Hev2.2, isolated promoter region cloned between Hind m and Bgl 
II sites of the pCambia 138 lZ vector ( cambia). For Hev2.3, deleted fragments of the isolated promoter region cloned between the Xba I and Hind 
ID sites of the pPGTV-KAN vector (Becker et al., 1992). 
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-254 AACT 
-250 TTATATTATG TGATGTTTTC CCCTTTTAAT TAACTTTATA TGGATTTTTT 
-200 TTTTCAAATG CCACCGCTCA ATTCACATTG CAACTTGGCG GTGGCACACA 
-150 ATGGCCGCTT TTGTTGACCA AGCTGATTTC TTCTCATGGC CATTTCCCCA 
-100 CATGCTTTCT TATATATATT ATTTCTTTTT ACATCCCAAG ATAAACACCT 
-50 TAGCCACATA TCTCTCTGCT ATAAATAAAG CCAAGTGAGC TTAGCTCATC 
+1 ATCATATAAT TTGCAAACCA GAAATTCAAG AATTGGGAAG AAATGGGAAG 
+51 AGTTATGAAT ATATTTATGG TTGTTTTATT ATGTTTAACA GGTGTTGCAA 
+101 TTGCTGAGCA ATGTGGTTGG CAAGCAGGTG GCAAGCTCTG CCCCAATAAC 
FIGURE 3. Nucleotide sequence of the hevein promoter region PHevl.1. The transcription start 
site (A) and translation initiation codon (ATG) are in bold letters. 
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-448 TTTTTGCA TGCATGTAAT TTTCAACTCA TTTATATATT TATTGTGAAA 
-400 TTTTTATTAT ATTATATATA TATATATATA TATATATATA TATATATATA 
-350 TATATATATA AATCAGAATT TAAGAGTAAA TGTATATTTT TTTTTGGATA 
-300 AATAAAATTT GAAATTTTGT TGCATCAAAT ATCATATTTG AATAATTAAC 
-250 TTTATATTAT GTGATGTTTT CCTCTTTTAA TTAACTTTAT ATTGATTTTT 
-200 TTTTTAAATG CCACCGCTCA ATTCACATTG CAACTTGGCG GTGGCACACA 
-150 ATGGCCACTT TTGTTGACCA AGCTGATTTC TTCTCATGGC CATTTCCCCA 
-100 CATGCTTTCT TATATGTATT ATTTCTTTTT ACATCCCAAG ATAAACACCT 
-50 TAGCCACATA TCTCTCTGCT ATAAATAAAG CCAAGTGAGC TTAGCTCATC 
+], ATCATATCAT TTGCAAACCA GAAAATCAAG AATTGGGAAG AAATGGGAAG 
+51 AGTTATGAAT ATATGTATGG TTGTATTATT ATGTTTAACA GGTGTTGCAA 
+101 TTGCTGAGCA ATGTGGTAGG CAAGCAGGTG GCAAGCTCTG CCCCAATAAC 
FIGURE 4. Nucleotide sequence of the hevein promoter region PHevl.2. The transcription start 
site (A) and translation initiation codon (ATG) are in bold letters. 
31 
# 
,._ 
-1776 CTTGTT TGCACATGAT GCGTTCAGGT 
-1750 GACCAATACT GGAACAGGAG ATAATGTGAC GGTGAAAATT GTTGATCAGT 
-1700 GCAGCAATGG AGGTTTGGAC TTAGACGAAG GTGCTTTCCC GCAGATAGAC 
-1650 ACCGATGGAA AAGGCTATGC TCAAGGCTAC CTTATTGGGA ACTACCAATT 
5 -1600 TGTGGATTGT GGTGATTGAA TTAACTAATA AGCAACTGAA TGTTAATTTC 
-1550 CAGAATAAGA AAACTTGCTG ATTGTAATCT CAAGTTCTAG AGTGAAAATA 
-1500 AAGATAATTA TATAAAATAT ATGGAAATTA TTATCCTAGA GGAAATTTTA 
-1450 TTTTTTTTTA AATTAATAAA ATTTTTGTAA TTAAAAATTT TACGAAAAAA 
-1400 AATCTAATAA AATAAATTTA TGTAAAATTA CTTTATTTTT TATAATAAAA 
10 -1350 TAATTACATT ATGTATGAAA CTAAGTAATC ATAGAATATA TATATATATT 
-1300 ATTTAGTTTA TGTGTCAAAT ATAATAGATT AATATTTTCT TTATTATTTT 
-1250 TCAAAATAAT TTTCATGTCA ACCCAATTAA ATAAATATCC AACTAATTTT 
-1200 TTTTTTAAAT ATTTTTATTT CACAGAGAAT AATTTGTATA TAAAAAATAA 
-1150 TTTTCATAAA AATATTTTTT ATTATTTAAT TTTAACATTA ATTAATGGTA 
15 -1100 CGTGTTCATA TTATATATGA ATAATATTTT TATATTTTAA TAAAATTATC 
-1050 AAAGTTGAGA AAATGATTTG CTCTTTTAAG TTCTCTCTTA AAAAAGAAAG 
-1000 TCATTTTTCT TAAAAATAAT TTAATTTCTC TTTGACTAAA ATATTTTTTG 
-950 TTAATTATTT TTTTAATACT CCAAACACAA AAAATGTGAA AAAAAAAATA 
-900 TTTTCCACGA CACAAACAAA CAGAATTTTA GCCAATCAAT TAGCGCAATT 
20 -850 TTCAACTCCC CCGCCTCCTA AAGGCTGGAC TGGTGTTGTT CCTGGAGGCT 
-BOO GATATCCTAA GCAGGTTTCT GGATTTGCAC TGATTCCATG ATGGTTGAGG 
-";450 CAAGAGGGTA TTTCTAATGA GTTTTTATTT AGCCCTCTTG GTTGTTGCCT 
-700 GCCACTGGAA ATCACCATGG AAACATATAT GAAGTCAAAT GACAATTTTT 
-650 ATTTTTTAAA TTTTCTGAGA GTGAGGAAAT GAATAAGAAG AATTTGTTAT 
25 -600 TTTTCTTTAA AGTCGTGTTA CTTTTACATA ATATATTAAG TCAAATTTAT 
-550 CGACTCAGTG AAAATAATTT ATATTTTATA AATAAGAAAA ATCTTGTTAT 
-500 ATAATTTAAT ATAAATTTTA TATCTTTTTT TTTTCAAGGA AATAAATTTT 
-450 ATATCTTGAT GATAAGATAG AGATAAGATC GAGTTAACCC TTGCGTTAAT 
-400 TGGATGTTTA AATGCTTAAT GCATGGCTAA GGAAATTAAT GTCTAAAATA 
30 -350 ACAGAAATGA GAAAAATAAA TGAAGGGTGA AAAATAAATA AAACCTGGCC 
-300 CTATGCTCTA TATTGGGGAT GGAGTGGGAG CCACCTAATG TGTCAGTGTT 
-250 CATCTTCGAA CAACGACTCG ATTCAAAGCA CACCCATGAA GCCGCTTCAC 
-200 ATCATCCCTT TGAAACTTTC CACCCTAATC AGCTATCACA CGATCTACTT 
-150 TCCAATCTCA TCAACGCTCC AAATCTCACC ACCATTCAGT CCACTTTCAC 
35 -100 TTCCTCCTTG TCCTAATCAT CTTTAATCCA TCGGGGTATT ATGGTAATTA 
-50 CATGATCAAG TCTCTCTGCT ATAAATAAAG CCAAGTGAGC TTAGCTCATC 
+1 ATCACATCAT TTGCATACCA GAAAATCAAG AATTGGGAAG AAATGGGAAG 
+51 AGTTATGAAT ACATTTATAG TTGTTTTATT ATGTTTAACA GGTGTTGCAA 
+101 TTGCTGAGCA ATGTGGTCGG CAAGCAGGTG GCAAGCTCTG CCCCAATAAC 
40 
FIGURE 5. Nucleotide sequence of the hevein promoter region PHev2. l. The transcription start 
site (A) and translation initiation codon (ATG) are in bold letters. 
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-1044 ATTT TTTTAATATT CCAAACACAA AAAATGTGAA AAAAAAAATA 
-1000 TTTTCCACGA CACAAACAAA CAGAATTTTA GCCAATCAAT TAGCGCAATT 
-950 TTCAACTCCC CCGCCTCCTA AAGGCTGGAC TGGTGTTGTT CCTGGAGGCT 
-850 GATATCCTAA GCAGGTTTCT GGATTTGCAC TGATTCCATG ATGGTTGAGG 
10 -800 CAAGAGGCTA TTTCTAATGA GTTTTTATTT AGCCCTCTGG GTTGTTGCCT 
-750 GCCACTGGAA ATCACCATGG AAACATATAT GAAGTCAAAT GACAATTTTT 
-700 ATTTTTTAAA TTTTCTGAGA GTGAGGAAAT GAATAAGAAG AATTTATTAT 
-650 TTTTCTTTAA AGTCGTGTTA CTTTTACATA ATATATTAAG TCAAATTTAT 
-600 CGACTCAGTG AAAATAATTT ATATTTTATA AATGAGAAAA ATCTTGTTAT 
15 -550 ATAATTTAAT ATAAATTTTA TATCTTTTTT TTTTTGAAGG AAATAAATTT 
-450 TATATCTTGA TGATAAGATA GAGATAAGAT CGAGTTAACC CTTGCATTAA 
-400 TTGGATGTTT AAATGCTTAA TGCATGGCTA AGGAAATTAA TGTCTAAAAT 
-350 AACAGAAATG AGAAAAATAA ATGAAGGGTG AAAAATAAAT AAAACCTGGC 
-300 CCTATGCTCT ATATTGGGGA TGGAGTGGGA GCCACCTAAT GTGTCAGTGT 
20 -250 TCATCTTCGA ACAACGACTC GATTCAAAGC ACACCCATGA AGCCGCTTCA 
-200 CATCATCCCT TTGAAACTTT CCACCCTAAT CAATATCACA CGATCTACTT 
. 
-150 TCCAATCTCA TCAACGCTCC AAATCTCACC ACCATTCAGT CCACTTTCAC 
-100 TTCCTCCTTG TCCTAATCAT CTTTAATCCA TCAGGGTATT ATGGTAATTA 
-50 CATGATCAAG TCTCTCTGCT ATAAATAAAG CCAAGTGAGC TTAGCTCATC 
25 +1 ATCACATCAT TTGCATACCA GAAAATCAAG AATTGGGAAG AAATGGGAAG 
+51 AGTTATGAAT ATATTTATAG TTGTTTTATT ATGTTTAACA GGTGTTGCAA 
+101 TTGCTGAGCA ATGTGGTCGG CAAGCAGGTG GCAAGCTCTG CCCCAATAAC 
30 FIGURE 6. Nucleotide sequence of the hevein promoter region PHev2.2. The transcription start 
site (A) and translation initiation codon (ATG) are in bold letters. 
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-919 CGACGGCCC GGGCTGGTAT 
-900 TCCAAACACA AAAAATGTGA AAAAAAAAAT ATATTTTCCA CGACACAAAC 
5 -850 AAACAGAATT TTAGCCAATC AATTAGCGCA ATTTTCAACT CCCCCGCTGC 
-800 TAAAGGCTGG ACTGGTGTTG TTCCTGGAGG CTGATATCCT AAGCAGGTTT 
-750 CTGGATTTGC ACTGATTCCA TGATGGTTGA GGCAAGAGGG TATTCCTAAT 
-700 GAGTTTTTAT TTAGCCCTCT TGGTTGTTGC CTGCCACTGG AAATCACCAT 
-650 GGAAACATAT ATGAAGTCAA ATGACAATTT TTATTTTTTA AATTTTCTGA 
10 -600 GAGTGAGGAA ATGAATAAGA AGAATTTGTT ATTTTTCTTT AAAGTCGTGT 
-550 TACTTTTACA TAATATATTA AGTCAAATTT GTCGACTCAG TGAAAATAAT 
-500 TTATATTTTA TAAATGAGAA AAATCTTGTT ATATAATTTA ATATAAATTT 
-450 TATATCTTTT TTTTTTGAAG GAAATAAATT TTATATCTTG ATGATAAGAC 
-400 AGAGATAAGA TCGAGTTAAC CCTTGCGTTA ATTGGATGTT TAAATGCTTA 
15 -350 ATGCATGGCT AAGGAAATTA ATGTCTAAAA TAACAGAAAT GAGAAAAATA 
-300 AATGAAGGGT GAAAAATAAA TAAAACCTGG CCCTATGCTC TATATTGGGG 
-250 ATGGAGTGGG AGCCACCTAA TGTGTCAGTG TTCATCTTCG AACAACGACT 
-200 CGATTCAAAG CACACCCATG AAGCCGCTTC ACATCATCCC TTTGAAACTT 
-1.50 TCCAATCTCA TCAACGCTCC AAATCTCACC ACCATTCAGT CCACTTTCAC 
20 -100 TTCCTCCTTG TCCTAATCAT CTTTAATCCA TCAGGGTATT ATGGTAATTA 
-50 CATGATCAAG TCTCTCTGCT ATAAATAAAG CCAAGTGAGC TTAGCTCATC 
+1 ATCACATCAT TTGCATACCA Gl:\AAATCAAG AATTGGGAAG AAATGGGAAG 
+51 AGTTATGAAT ATATTTATAG TTGTTTTATT ATGTTTAACA GGTGTTGCAA 
+101 TTGCTGAGCA ATGTGGTCGG CAAGCAGGTG GCAAGCTCTG CCCCAATAAC 
25 +151 CTATGTTGTA GCCAGTGGGG GTGGTGTGGC TCCACTGATG AATATTGTTC 
+201 ACCTG 
FIGURE 7. Nucleotide sequence of the PHev2.3 (HevP) hevein promoter region, 
30 isolated by nested PCR. The transcription start site (A) and translation initiation codon (ATG) are in 
bold letters. 
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5 FIGURE 8. Schematic diagram of the PCR-generated nested deletion fragments obtained from the 
hevein promoter region HevP (Phev2.3) and cloned in pPGTV-KAN. The promoter sequences were 
joined to the uidA reporter gene. The 5' and 3' end points of the promoter sequences are numbered 
from the transcription start site of the hevein gene. pPGTV-KAN-1 (HevP-1 : -275 to +55); 
pPGTV-KAN-2 (HevP-2: 
10 -389 to +55); pPGTV-KAN-3 (HevP-3: -687 to +55) and pPGTV-KAN-4 (HevP-: -919 to +55). 
The binary vector pPGTV-KAN contains unique cloning sites upstream of the uidA gene which 
allows the insertion of promoter fragments. The T-DNA nopaline synthase (pAnos) and gene 7 
(pAg7) poly (A) signais follow the uidA gene and the selectable marker (nptII) genes respectively. 
Arrows indicate direction of transcription; R, right T-DNA border; L, left T-DNA border. 
15 Abbreviations : 
St=Sst I, E= Eco RI, Sm=Sma I, X=Xba I, S=Sal I, H=Hind III, B=Bgl II, 
Bm=Bam HI, npt II= neomycin phosphotransferase II gene. 
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FIGURE 9. Fluorometric analysis of the GUS activity in transgenic rice plants (TI) carrying a 
single- copy of the uidA gene driven by PHev2.1, in response to mechanical wounding. For each 
time point, the GUS activity value represented is the average value from 4 different transgenic lines, 
each line being represented by the average value from 3 Tl progenies. Wounding was performed by 
pricking leaves with needles. Wounded leaves were collected 1, 3, 6, 10 and 24 hours after 
wounding (Tl, T3, T6, TlO, T24 respectively). TO: unwounded plants. TlOS: systemic response of 
unwounded intermediary leaves located between 2 wounded leaves and analysed 10 hours after 
wounding. The statistical significance was evaluated by Fisher test (P<O.O 1 ). 
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FIGURE 10. Fluorometric analysis of the GUS activity in transgenic rice plants (Tl) carrying a 
single copy of the uidA gene driven by PHev2. l, in response to fungal infection. For each event, 
the GUS acivity value presented is the average from 6 different transgenic lines, each being 
10 represented by the average value from 3 Tl progenies. Control plants were sprayed with 0.5% 
gelatin and anlaysed at the time points O (Co) or 4 days after treatment (C4) ; 4 : plants innoculated 
with spores of Magnaporthe grisea (THl 6) in 0.5% gelatin and analysed 4 days after innoculation. 
The statistical significance was evaluated by Fisher test (P<0.01). 
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